Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes.

Gbadebo TD, Trimble RW, Khoo MS, Temple J, Roden DM, Anderson ME.

Circulation. 2002 Feb 12;105(6):770-4.

2.
3.

K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.

Hasumi H, Matsuda R, Shimamoto K, Hata Y, Kaneko N.

Eur J Pharmacol. 2007 Jan 19;555(1):54-60. Epub 2006 Oct 17.

PMID:
17112502
4.

[Calmodulin antagonist inhibits torsade de pointes induced by d-sotalol in an isolated rabbit heart model].

Pu J, Zhang CT, Bai R, Liu N, Li Y, Wang L.

Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Apr;33(4):364-8. Chinese.

PMID:
15932674
5.

Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.

Wang WQ, Robertson C, Dhalla AK, Belardinelli L.

J Pharmacol Exp Ther. 2008 Jun;325(3):875-81. doi: 10.1124/jpet.108.137729. Epub 2008 Mar 5.

6.

Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.

Zabel M, Hohnloser SH, Behrens S, Li YG, Woosley RL, Franz MR.

J Cardiovasc Electrophysiol. 1997 Oct;8(10):1148-58.

PMID:
9363818
7.

Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.

Kirchhof P, Franz MR, Bardai A, Wilde AM.

J Am Coll Cardiol. 2009 Jul 7;54(2):143-9. doi: 10.1016/j.jacc.2009.03.043.

9.

Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.

Shimizu W, Antzelevitch C.

J Electrocardiol. 1999;32 Suppl:177-84. Review.

PMID:
10688323
10.

The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.

Topilski I, Rogowski O, Rosso R, Justo D, Copperman Y, Glikson M, Belhassen B, Hochenberg M, Viskin S.

J Am Coll Cardiol. 2007 Jan 23;49(3):320-8. Epub 2007 Jan 4.

11.

Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.

Milberg P, Reinsch N, Osada N, Wasmer K, Mönnig G, Stypmann J, Breithardt G, Haverkamp W, Eckardt L.

Basic Res Cardiol. 2005 Jul;100(4):365-71. Epub 2005 Jun 10.

PMID:
15944809
12.

Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.

Carlsson L, Abrahamsson C, Drews L, Duker G.

Circulation. 1992 Apr;85(4):1491-500.

PMID:
1555289
13.

Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?

Medina-Ravell VA, Lankipalli RS, Yan GX, Antzelevitch C, Medina-Malpica NA, Medina-Malpica OA, Droogan C, Kowey PR.

Circulation. 2003 Feb 11;107(5):740-6.

14.
15.

Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.

Milberg P, Hilker E, Ramtin S, Cakir Y, Stypmann J, Engelen MA, Mönnig G, Osada N, Breithardt G, Haverkamp W, Eckardt L.

J Cardiovasc Electrophysiol. 2007 Jun;18(6):647-54. Epub 2007 Mar 28.

PMID:
17388913
16.

Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.

Aiba T, Shimizu W, Inagaki M, Noda T, Miyoshi S, Ding WG, Zankov DP, Toyoda F, Matsuura H, Horie M, Sunagawa K.

J Am Coll Cardiol. 2005 Jan 18;45(2):300-7.

17.

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W.

J Pharmacol Exp Ther. 2002 Oct;303(1):218-25.

18.

Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.

Gilmour RF Jr, Riccio ML, Locati EH, Maison-Blanche P, Coumel P, Schwartz PJ.

J Am Coll Cardiol. 1997 Jul;30(1):209-17.

19.

Effects of sarcolemmal Ca(2+) entry, ryanodine function, and kinase inhibitors on a rabbit model of heart failure.

Kijtawornrat A, Ziolo MT, Nishijima Y, Roche BM, Hamlin RL.

Int Heart J. 2010 Jul;51(4):285-90.

20.

Supplemental Content

Support Center